(Q51896968)

17 April 2018

title

Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. (English)

1 reference

17 April 2018

1 reference

8

Hokken-Koelega AC

1 reference

17 April 2018

author name string

Festen DA

1

1 reference

17 April 2018

Wevers M

2

1 reference

17 April 2018

Lindgren AC

3

1 reference

17 April 2018

Böhm B

4

1 reference

17 April 2018

Otten BJ

5

1 reference

17 April 2018

Wit JM

6

1 reference

17 April 2018

Duivenvoorden HJ

7

1 reference

17 April 2018

publication date

19 November 2007

1 reference

17 April 2018

published in

Clinical Endocrinology

1 reference

17 April 2018

volume

68

1 reference

17 April 2018

issue

6

1 reference

17 April 2018

page(s)

919-925

1 reference

17 April 2018

Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

Critical periods of brain growth and cognitive function in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2007.03126.X

10.1111/J.1365-2265.2007.03126.X

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

18031326

1 reference

17 April 2018